Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5-methyltetrahydrofolate-homocysteine S-methyltransferase, commonly known as methionine synthase (MTR), is a vital cytoplasmic enzyme that catalyzes the transfer of a methyl group from 5-methyltetrahydrofolate to L-homocysteine, yielding tetrahydrofolate and L-methionine. This reaction represents a critical junction linking the folate and methionine cycles, which are essential for DNA synthesis, nucleotide production, and the generation of S-adenosylmethionine (SAM)—the primary methyl donor for cellular methylation reactions. MTR requires methylcobalamin (a form of vitamin B12) as an essential cofactor to facilitate this methyl transfer.
In clinical medicine, MTR is a well-known target of nitrous oxide, an anesthetic gas that irreversibly inactivates the enzyme by oxidizing its cob(I)alamin cofactor, potentially leading to functional vitamin B12 deficiency, megaloblastic anemia, and neurotoxicity. Conversely, cobalamin supplements such as cyanocobalamin and mecobalamin are administered to support or restore MTR activity in deficiency states. Additionally, MTR has emerged as a potential therapeutic target in oncology, where its inhibition is being explored to exploit the 'methyl folate trap' and disrupt cancer cell proliferation.
Nitrous oxide irreversibly inactivates methionine synthase by oxidizing the essential cob(I)alamin cofactor to the inactive cob(II)alamin state, disrupting the folate and methionine cycles. Cobalamin derivatives act as cofactors or precursors to the active methylcobalamin cofactor, restoring enzyme activity in deficiency states.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-methyltetrahydrofolate-homocysteine S-methyltransferase (MTR).